Nektar <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Amends Bylaws, Increases Authorized Shares and Announces Reverse Stock Split
Nektar Therapeutics announced amendments to its bylaws, including an increase in authorized common stock shares from 300 million to 390 million, effective June 6, 2025. Additionally, a reverse stock split at a ratio of one-for-fifteen will take effect on June 8, 2025, consolidating every fifteen shares into one. Trading on a split-adjusted basis will begin on June 9, 2025, under the existing symbol "NKTR" with a new CUSIP number.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nektar Therapeutics published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-052141), on June 06, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。